MindWave Innovations Announces $NILA Token Listing on PICOL Platform
MindWave Innovations Inc., a subsidiary of Apimeds Pharmaceuticals US, Inc., has launched trading for its $NILA token on the South Korean platform PICOL.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
MindWave Innovations Inc., a subsidiary of Apimeds Pharmaceuticals US, Inc., has launched trading for its $NILA token on the South Korean platform PICOL.
MindWave Innovations, a subsidiary of Apimeds Pharmaceuticals US, Inc., is providing the technical backend for a new $25 million ecosystem credit initiative launched by AQUAE Labs.
MindWave Innovations Inc., a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc., has signed a joint venture agreement with Skalup Capital to launch a Bermuda-based insurance and technology business.
MindWave Innovations, a subsidiary of Apimeds Pharmaceuticals US, Inc., has announced the expansion of its MindChain technology into the climate finance, sports media, and insurance sectors.
Filed: 2026-10-13 AccNo: 0001213900-26-108780 Size: 238 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
MindWave Innovations Inc. USA, a subsidiary of Apimeds Pharmaceuticals US, Inc., signed three blockchain network agreements within 10 days with AQUAE Holdings (climate finance), Flash Sports & Media Holdings (sports media), and BlockAssure Inc. (insurance). Each agreement follows the same model where MindWave builds and operates dedicated MindChain networks while receiving 20% token/credit allocations. However, the parent company disclosed substantial doubt about its ability to continue as a going concern.